| human | Q5 |
| P6178 | Dimensions author ID | 0110231435.43 |
| P227 | GND ID | 143226967 |
| P213 | ISNI | 0000000113358309 |
| P1207 | NUKAT ID | n2012069125 |
| P496 | ORCID iD | 0000-0002-6350-3911 |
| P3829 | Publons author ID | 1643617 |
| P1053 | ResearcherID | B-1613-2010 |
| P214 | VIAF ID | 165537122 |
| P10832 | WorldCat Entities ID | E39PBJjtdvpx8jYgdQfmKtDcyd |
| P735 | given name | Rolf | Q2163153 |
| Rolf | Q2163153 | ||
| P106 | occupation | researcher | Q1650915 |
| biochemist | Q2919046 | ||
| P21 | sex or gender | male | Q6581097 |
| Q41592743 | "Inverse signaling" of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells |
| Q39995709 | A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis |
| Q43562120 | ATP and adenosine induce ramification of microglia in vitro |
| Q38070920 | An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology. |
| Q55472560 | Angiogenesis factors in gliomas: a new key to tumour therapy? |
| Q74506796 | Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor |
| Q40629745 | Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts. |
| Q40615308 | CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26. |
| Q24292789 | CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors |
| Q39735092 | CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). |
| Q39398560 | CXCL12 mediates apoptosis resistance in rat C6 glioma cells. |
| Q38802357 | CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1/2 Signaling Pathway |
| Q40246451 | Cannabinoid receptors in human astroglial tumors |
| Q42458143 | Catecholamines and lipopolysaccharide synergistically induce the release of interleukin-6 from thymic epithelial cells |
| Q53236986 | Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia. |
| Q42825650 | Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles |
| Q28570203 | Cyclic strain influences the expression of the vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 alpha (HIF-1alpha) in tendon fibroblasts |
| Q40253869 | Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells |
| Q44052624 | Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. |
| Q46381951 | Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes |
| Q42466122 | Effect of transmitters and co-transmitters of the sympathetic nervous system on interleukin-6 synthesis in thymic epithelial cells |
| Q80204672 | Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes |
| Q33829364 | Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells. |
| Q40508431 | Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage |
| Q40413807 | Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. |
| Q83172247 | Expression and regulation of human beta-defensin-2 in osteoarthritic cartilage |
| Q39667924 | Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors |
| Q95807453 | Expression of VEGF and its receptors in different brain tumors |
| Q47841442 | Expression of VEGFR-1 and VEGFR-2 in degenerative Achilles tendons. |
| Q48115550 | Expression of stem cell markers in human astrocytomas of different WHO grades |
| Q54700006 | Expression of vascular endothelial growth factor during healing of the meniscus in a rabbit model. |
| Q44835980 | Functional significance of vascular endothelial growth factor receptor expression on human glioma cells |
| Q37185733 | Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16. |
| Q49719103 | Glioma infiltration and extracellular matrix: key players and modulators. |
| Q28254461 | Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors |
| Q47970474 | Hypoxia and PDGF have a synergistic effect that increases the expression of the angiogenetic peptide vascular endothelial growth factor in Achilles tendon fibroblasts |
| Q41002561 | Immunoelectronmicroscopic analysis of the ligand-induced internalization of the somatostatin receptor subtype 2 in cultured human glioma cells |
| Q43136220 | Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2. |
| Q39977663 | Iron oxide-loaded liposomes for MR imaging |
| Q37972489 | Lost in disruption: role of proteases in glioma invasion and progression. |
| Q33340257 | MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses |
| Q39741940 | Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells |
| Q48820353 | Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas |
| Q40980572 | Molecular analysis of the somatostatin receptor subtype 2 in human glioma cells |
| Q84077118 | Multiple trauma induces serum production of host defence peptides |
| Q35541948 | Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7. |
| Q43088850 | Neuropeptides exert direct effects on rat thymic epithelial cells in culture |
| Q46313866 | Osteoblasts participate in the innate immunity of the bone by producing human beta defensin-3. |
| Q33320839 | Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas |
| Q79444286 | Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas |
| Q44208814 | Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas |
| Q54779293 | Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. |
| Q54694303 | Production of endogenous antibiotics in articular cartilage. |
| Q50877790 | Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes. |
| Q56992784 | Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat |
| Q42461900 | Receptors and effects of the inhibitory neuropeptide somatostatin in microglial cells |
| Q55463466 | SP100 reduces malignancy of human glioma cells. |
| Q40705234 | Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells |
| Q42502856 | Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells |
| Q38806424 | Stem cell markers in glioma progression and recurrence |
| Q40287592 | TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease |
| Q36871963 | Targeting pleiotropin to treat osteoarthritis. |
| Q54778678 | The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers. |
| Q34204614 | The antimicrobial peptide lysozyme is induced after multiple trauma |
| Q39962454 | The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6. |
| Q55462721 | The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells. |
| Q42203980 | The retinal pigment epithelium (RPE) induces FasL and reduces iNOS and Cox2 in primary monocytes |
| Q40101342 | The role of Fc-receptors in the uptake and transport of therapeutic antibodies in the retinal pigment epithelium |
| Q39903794 | The role of human beta-defensin-2 in bone |
| Q44695645 | The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model |
| Q36184209 | The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. |
| Q73401950 | The splice variants 120 and 164 of the angiogenic peptide vascular endothelial cell growth factor (VEGF) are expressed during Achilles tendon healing |
| Q42517411 | The transcription factor Forkhead box P3 (FoxP3) is expressed in glioma cells and associated with increased apoptosis |
| Q28601403 | Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling |
| Q42016712 | Tumor necrosis factor alpha-dependent aggrecan cleavage and release of glycosaminoglycans in the meniscus is mediated by nitrous oxide-independent aggrecanase activity in vitro |
| Q43579273 | Tumor risk by tissue engineering: cartilaginous differentiation of mesenchymal stem cells reduces tumor growth |
| Q80370209 | VEGF expression in adult permanent thyroid cartilage: implications for lack of cartilage ossification |
| Q39818323 | VEGFR-3/Flt-4 mediates proliferation and chemotaxis in glial precursor cells |
| Q40584038 | Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes |
| Q40692165 | Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells |
Search more.